Basal Cell Carcinoma Subtype Reporting Varies by Practice, May Put Patients at Risk Basal Cell Carcinoma Subtype Reporting Varies by Practice, May Put Patients at Risk
Underreporting of basal cell carcinoma (BCC) subtypes occurs in academic, teaching and nonteaching institutions and may place patients at risk for inadequate or inappropriate therapy, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 26, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
OCT for Diagnosis of Basal Cell Carcinoma OCT for Diagnosis of Basal Cell Carcinoma
This review explores how optical coherence tomography, a noninvasive near-infrared light imaging technology, might improve the diagnosis and management of basal cell carcinoma.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Mayo Clinic Minute: 3 types of skin cancer
There's no questions that sun exposure increases your risk of skin cancer. ?Skin cancer is the most common type of cancer in the U.S., according to the Centers for Disease Control and Prevention.?Dr. Dawn Davis, a Mayo Clinic dermatologist, says there are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 7, 2019 Category: Databases & Libraries Source Type: news
Childhood Cancer Survivors at High Risk for Skin Malignancies Childhood Cancer Survivors at High Risk for Skin Malignancies
As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing basal cell carcinoma, a Dutch study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Childhood cancer survivors at high risk for skin malignancies
(Reuters Health) - As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing common skin malignancies known as basal cell carcinoma, a Dutch study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news
Targeted and Immune Therapeutics for Basal Cell Cancer Targeted and Immune Therapeutics for Basal Cell Cancer
Review the use of hedgehog pathway inhibitors and other novel treatment options for metastatic basal cell carcinoma.Annals of Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 4, 2019 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news
Low-risk cancers should be renamed 'indolent', oncologist urges
Birte Twisselmann (pictured) - an editor at The BMJ - was reassured following her basal cell carcinoma diagnosis when a colleague said 'well, it ’s not really cancer - you won’t die from it'. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2019 Category: Consumer Health News Source Type: news
Topical Photodynamic Therapy for Basal Cell Carcinoma Topical Photodynamic Therapy for Basal Cell Carcinoma
How does topical photodynamic therapy compare in efficacy with other treatment options for low-risk basal cell carcinoma?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Skin Cancer | Medscape Skin Cancer | Medscape
Nonmelanoma skin cancer primarily comprises basal cell carcinoma and squamous cell carcinoma. Other, rarer types of nonmelanoma skin cancer include dermatofibrosarcoma protuberans, Merkel cell carcinoma, and Kaposi ' s sarcoma. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news
Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
TAIPEI, Taiwan and SAN DIEGO, Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Senhwa Biosciences Inc. (TPEx: 6492) announced today that FDA has approved its IND application for basal cell carcinoma (BCC). To accelerate the development of this ne... Biopharmaceuticals, Oncology, FDA Senhwa Biosciences, Silmitasertib, basal cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news
Study: Best Treatments for Basal Cell Carcinoma
When treating low-risk primary basal cell carcinoma (BCC), surgery and external beam radiation yield a better chance of a cure and a lower recurrence rate compared with other treatment modalities. This is the finding of a recent meta-analysispublished in theAnnals of Internal Medicine. (Source: CancerNetwork)
Source: CancerNetwork - October 17, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Pulse Biosciences launches NPS cutaneous wart feasibility study
Pulse Biosciences (NSDQ:PLSE) said today that it launched a clinical feasibility study of its Nano-Pulse Stimulation platform intended to treat cutaneous warts.
The Nano-Pulse Stimulation system is a novel, non-thermal tech platform designed to deliver nanosecond duration energy pulses intended to disrupt functions of internal cell structures while maintaining outer cell membranes, the Hayward, Calif.-based company said.
Pulse Biosciences said that the device’s mechanism of action has been shown in previous clinical studies to eliminate treated cells with only mild inflammatory response and favorable healing and co...
Source: Mass Device - October 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Cosmetic/Aesthetic Pulse Biosciences Source Type: news
Sparse Evidence to Select Optimal Treatment for Basal Cell Carcinoma Sparse Evidence to Select Optimal Treatment for Basal Cell Carcinoma
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Review: Treatments for Primary Basal Cell Carcinoma Compared
Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external - beam radiation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 18, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news
